|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option Right to Buy | $ 37.63 | 07/06/2018 | D | 10,000 | (8)(9) | 03/22/2020 | Common Stock | 10,000 | (8) (9) | 0 | D | ||||
| Stock Option Right to Buy | $ 37.83 | 07/06/2018 | D | 25,000 | (8)(9) | 02/07/2021 | Common Stock | 25,000 | (8) (9) | 0 | D | ||||
| Stock Option Right to Buy | $ 62.86 | 07/06/2018 | D | 12,886 | (8)(9) | 02/16/2022 | Common Stock | 12,886 | (8) (9) | 0 | D | ||||
| Stock Option Right to Buy | $ 48.88 | 07/06/2018 | D | 36,181 | (8)(9) | 02/11/2023 | Common Stock | 36,181 | (8) (9) | 0 | D | ||||
| Stock Option Right to Buy | $ 65.8 | 07/06/2018 | D | 28,762 | (8)(9) | 02/10/2024 | Common Stock | 28,762 | (8) (9) | 0 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| Hussain Muhammad Raghib C/O CAVIUM, INC. 2315 N. FIRST STREET SAN JOSE, CA 95131 |
Chief Operating Officer | |||
| /s/ Muhammad Raghib Hussain | 07/06/2018 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Disposed of pursuant to the Agreement and Plan of Merger, dated as of November 19, 2017 (the "Merger Agreement" and, the transaction contemplated therein, the "Merger"), by and among Cavium, Inc. (the "Company"), Marvell Technology Group Ltd. ("Marvell"), and Kauai Acquisition Corp., an indirect wholly owned subsidiary of Parent ("Merger Sub"), whereby each share of Company common stock was canceled and automatically converted into $40.00 in cash, without interest, and 2.1757 shares of Marvell common stock (together, the "Per Share Amount"), with the fractional shares being paid in cash as provided in the Merger Agreement. The market value of the Per Share Amount is $86.43 per share, based on the trading price of Marvell common stock as of the end of trading on July 5, 2018. |
| (2) | Held in trusts of which the reporting person is the trustee, for the benefit of members of his immediate family. |
| (3) | Represents shares of common stock of the Company underlying time-based restricted stock units ("RSUs"). |
| (4) | Disposed of pursuant to the Merger Agreement, whereby at the effective time of the Merger (the "Effective Time") each outstanding and unvested RSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted RSUs"), equal to the product of (x) the number of shares of Company common stock subject to such RSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted RSU is subject to the same terms and conditions as were applicable under such RSU prior to the Effective Time. |
| (5) | Represents shares of common stock of the Company underlying performance-based restricted stock units ("PRSUs"). Until the Merger, the Reporting Person's right to this PRSU remained subject to the satisfaction of certain performance criteria. |
| (6) | Disposed of pursuant to the Merger Agreement, whereby at the Effective Time each outstanding and unvested PRSU was assumed and converted in the Merger into that number of Marvell restricted stock units of Marvell common stock, rounded down to the nearest whole share ("Converted PRSUs"), equal to the product of (x) the number of shares of Company common stock subject to such PRSU, assuming achievement of target-level performance with respect to each performance period, performance cycle or measurement cycle applicable to such PRSU and (y) the Conversion Ratio (calculated to equal 4.0339). Any Converted PRSU shall (A) vest based on the vesting date set forth in the award agreement applicable to such PRSU prior to the Effective Time, subject only to the continued service of the grantee with the Company, Marvell or any of their affiliates through the applicable vesting date, (B) not be subject to any performance based vesting terms following the Effective Time and (continued in footnote 7) |
| (7) | (C) otherwise be subject to the same terms and conditions as were applicable under such PRSU prior to the Effective Time. |
| (8) | Pursuant to the Merger Agreement, each outstanding Company stock option, other than Company stock options held by non-employee directors (other than directors who will serve on Marvell's board of directors following the Merger), whether vested or unvested, was assumed and converted into an option to purchase that number of shares of Marvell common stock (rounded down to the nearest whole share) equal the product of (x) the number of shares of Company common stock for which the Company stock option was exercisable multiplied by (y) the sum of (A) 2.1757 and the quotient obtained by dividing (i) $40.00 by (ii) the volume weighted average trading price of Marvell common stock on Nasdaq for the five (5) consecutive trading days ending on the trading day immediately preceding the closing date of the Merger (the sum, the "Conversion Ratio," (continued in footnote 9) |
| (9) | calculated to equal 4.0339) at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (1) the per share exercise price for the Company common stock for which the Company stock option was exercisable divided by (2) the Conversion Ratio (calculated to equal 4.0339). |